Search research articles
Contact Us
Filters
Showing results (171-180 of 181) with videos related to
Page
of 19
Sort By:
JHEP Reports : Innovation in Hepatology
|
January 20, 2025
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis
Alessio Gerussi, Oliver Lester Saldanha, Giorgio Cazzaniga, et al.
Liver Cancer
|
December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy
Camilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Nature
|
January 17, 2020
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez, Aurélien de Reyniès, Emily Z Keung, et al.
Journal of Pathology Informatics
|
May 21, 2026
How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology
Joshua Pantanowitz, Christopher D Manko, John Majewski, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 27, 2025
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab
Claudia Campani, Clelia Galvanin, Ju Hyun Shim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2021
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
Cong Trung Nguyen, Stefano Caruso, Pascale Maille, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 9, 2024
Validation of Metallothionein Immunohistochemistry as a Highly Sensitive Screening Test for Wilson Disease
Nadarra L Stokes, Ameya Patil, Oyedele Adeyi, et al.
Hepatology (Baltimore, Md.)
|
June 13, 2025
Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement
Guido Carpino, Diletta Overi, Rocio Ir Macias, et al.
The Lancet. Oncology
|
November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Qinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Journal of Hepatology
|
August 20, 2022
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
Julien Calderaro, Luca Di Tommaso, Pascale Maillé, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 181) with videos related to
Sort By:
Page
of 19
JHEP Reports : Innovation in Hepatology
|
January 20, 2025
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis
Alessio Gerussi, Oliver Lester Saldanha, Giorgio Cazzaniga, et al.
Liver Cancer
|
December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy
Camilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Nature
|
January 17, 2020
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez, Aurélien de Reyniès, Emily Z Keung, et al.
Journal of Pathology Informatics
|
May 21, 2026
How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology
Joshua Pantanowitz, Christopher D Manko, John Majewski, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 27, 2025
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab
Claudia Campani, Clelia Galvanin, Ju Hyun Shim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2021
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
Cong Trung Nguyen, Stefano Caruso, Pascale Maille, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 9, 2024
Validation of Metallothionein Immunohistochemistry as a Highly Sensitive Screening Test for Wilson Disease
Nadarra L Stokes, Ameya Patil, Oyedele Adeyi, et al.
Hepatology (Baltimore, Md.)
|
June 13, 2025
Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement
Guido Carpino, Diletta Overi, Rocio Ir Macias, et al.
The Lancet. Oncology
|
November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Qinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Journal of Hepatology
|
August 20, 2022
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
Julien Calderaro, Luca Di Tommaso, Pascale Maillé, et al.
Page
of 19